MYUNGIN PHARM.CO., LTD Q3 operating profit KRW 27.1 billion on sales of KRW 76.8 billion
AI summary · Not investment advice
Myungin Pharm sold KRW 76.8 billion worth in Q3 and earned KRW 27.1 billion from its main business, up 23.5% from a year earlier and down 2.0% from the prior quarter.
Operating profit · 3 months
KRW 27.1 billion
Key facts
- Revenue (3 months)
- KRW 76.8 billion
- Net income (3 months)
- KRW 21.2 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 72.7 billion
- Revenue (year to date)
- KRW 225.1 billion
- Operating profit (prior-year 3 months)
- KRW 21.9 billion
- Operating profit (year to date)
- KRW 79.8 billion
- Net income (prior-year 3 months)
- KRW 18.5 billion
- Net income (year to date)
- KRW 68.3 billion
Commentary
AI commentary · Not investment advice
What happened
Myungin Pharm filed its quarterly report with consolidated results for the third quarter. Sales for the latest 3 months were KRW 76.84 billion. That is 5.7% above the same 3 months a year earlier (KRW 72.70 billion) and 1.0% above the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 27.06 billion. That is 23.5% above a year earlier (KRW 21.91 billion) and 2.0% below the previous quarter. Net income (final profit after taxes and other costs) was KRW 21.22 billion. That is 14.4% above a year earlier (KRW 18.55 billion) and 12.8% below the previous quarter.
What changes for shareholders
For the year to date, from January 1 to September 30, sales were KRW 225.08 billion. Operating profit was KRW 79.78 billion and net income was KRW 68.27 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
M